Neurocrine wins FDA nod for CAH therapy

1 bulan yang lalu

Neurocrine Biosciences (NASDAQ:NBIX) has received FDA support for Crenessity (crinecerfont) arsenic a shape of curen for adults and children pinch classical congenital adrenal hyperplasia (CAH), a uncommon hormonal disorder.
The San Diego, California-based biotech announced precocious Friday that Crenessity has become